Literature DB >> 22129805

Epigenetics: Worth another look?

Nicola McCarthy.   

Abstract

Year:  2011        PMID： 22129805     DOI： 10.1038/nrc3187

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.

Authors:  Rosalyn A Juergens; John Wrangle; Frank P Vendetti; Sara C Murphy; Ming Zhao; Barbara Coleman; Rosa Sebree; Kristen Rodgers; Craig M Hooker; Noreli Franco; Beverly Lee; Salina Tsai; Igor Espinoza Delgado; Michelle A Rudek; Steven A Belinsky; James G Herman; Stephen B Baylin; Malcolm V Brock; Charles M Rudin
Journal:  Cancer Discov       Date:  2011-11-09       Impact factor: 39.397
  1 in total
  4 in total

1.  ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway.

Authors:  Li Pang; Jian-Fang Li; Liping Su; Mingde Zang; Zhiyuan Fan; Beiqin Yu; Xiongyan Wu; Chen Li; Min Yan; Zheng-Gang Zhu; Bingya Liu
Journal:  J Gastroenterol       Date:  2017-03-17       Impact factor: 7.527

2.  Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo.

Authors:  Dafeng Yang; Christina M Torres; Kankana Bardhan; Mary Zimmerman; Tracy L McGaha; Kebin Liu
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

Review 3.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

4.  An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma.

Authors:  Qian Mei; Meixia Chen; Xuechun Lu; Xiang Li; Feng Duan; Maoqiang Wang; Guangbin Luo; Weidong Han
Journal:  Oncotarget       Date:  2015-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.